References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Songetal(1998)ModulationofthetumordispositionofvincaalkaloidsbyPSC833invitroandinvivo.J.Pharmacol.Exp.Ther.287963PMID:9864280
Godaetal(2007)CompleteinhibitionofP-glycoproteinbysimulataneoustreatmentwithadistinctclassofmodulatorsandtheUIC2monoclonalantibody.J.Pharmacol.Exp.Ther.32081PMID:17050779
Shenetal(2008)Quantitationofdoxorubicineuptake,efflux,andmodulationofmultidrugresistance(MDR)inMDRhumancancercells.J.Pharmacol.Exp.Ther.32495PMID:17947497
Shenetal(2009)DynamicassessmentofmitoxantroneresistanceandmodulationofmultidrugresistancebyValspodar(PSC833)inmultidrugresistancehumancancercells.J.Pharmacol.Exp.Ther.330423PMID:19423841
Keywords:PSC833,supplier,PSC833,P-glycoprotein,inhibitors,inhibits,P-gp,cyclosporin,A,analog,analogue,ABCB1,Valspodar,Multidrug,Transporters,Multidrug,Transporters,TocrisBioscience